About GlycoEra
GlycoEra develops biologics to selectively degrade specific circulating proteins that drive autoimmune diseases. Its platform designs therapeutics to target disease-causing proteins like autoantibodies. The company aims to improve patient outcomes by enabling earlier intervention in autoimmune conditions.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Wädenswil, Switzerland
Year Founded
2021
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
glycoera.com
Domain Registered Date
Mar 5, 2020
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $130,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $49,000,000 · Series-A
- Milestone
Company founded
Wädenswil, Switzerland
- Milestone
X account created (@glycoera)
11 followers
- Milestone
Website domain registered
glycoera.com
Investors & Backers
5AM Ventures
Agent Capital
Bristol-Myers Squibb
Catalio
LifeArc Ventures
LimmaTech Biologics
MP Healthcare Venture Management
Novo Holdings
Qatar Investment Authority
Roche Venture Fund
Sixty Degree Capital
Sofinnova Partners
Funding History
Series-B+
· May 27, 2025
$130,000,000 fundraisingfox.com
Series-A
· Nov 5, 2021
$49,000,000 Source
Founders & Leadership
Amir Faridmoayer
Founder
Work email & phone locked
Unlock →
Dominique N. Sirena
Founder
Work email & phone locked
Unlock →
Ganesh Kaundinya
President and CEO
Work email & phone locked
Unlock →
Greg Fralish
Chief Business Officer
Work email & phone locked
Unlock →
Petra Duda
Chief Medical Officer
Work email & phone locked
Unlock →
Tanmoy Ganguly
Chief Scientific Officer
Work email & phone locked
Unlock →
Veronica Gambillara Fonck
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026